{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T13:26:16Z","timestamp":1724592376845},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T00:00:00Z","timestamp":1474070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III","award":["PI13\/00550"],"award-info":[{"award-number":["PI13\/00550"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00430-016-0479-5","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T09:45:55Z","timestamp":1474105555000},"page":"31-39","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?"],"prefix":"10.1007","volume":"206","author":[{"given":"Cristina","family":"El Haj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolors","family":"Garcia-Somoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fe","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Cabellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Cabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ariza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,17]]},"reference":[{"key":"479_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","volume":"358","author":"PS Stewart","year":"2001","unstructured":"Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135\u2013138","journal-title":"Lancet"},{"key":"479_CR2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","volume":"56","author":"J Lora-Tamayo","year":"2013","unstructured":"Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, S\u00e1nchez-Somolinos M, Baraia-Etxaburu JM et al (2013) A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis 56:182\u2013194","journal-title":"Clin Infect Dis"},{"key":"479_CR3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1\u2013e25","journal-title":"Clin Infect Dis"},{"key":"479_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00003086-200508000-00003","volume":"437","author":"JW Costerton","year":"2005","unstructured":"Costerton JW (2005) Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 437:7\u201311","journal-title":"Clin Orthop Relat Res"},{"key":"479_CR5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.5301\/ijao.5000145","volume":"35","author":"EN Hansen","year":"2012","unstructured":"Hansen EN, Zmistowski B, Parvizi J (2012) Periprosthetic joint infection: what is on the horizon? Int J Artif Organs 35:935\u2013950","journal-title":"Int J Artif Organs"},{"key":"479_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkh309","volume":"54","author":"MJ Schultz","year":"2004","unstructured":"Schultz MJ (2004) Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother 54:21\u201328","journal-title":"J Antimicrob Chemother"},{"key":"479_CR7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkr040","volume":"66","author":"Y Cai","year":"2011","unstructured":"Cai Y, Chai D, Wang R, Bai N, Liang BB, Liu Y (2011) Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review. J Antimicrob Chemother 66:968\u2013978","journal-title":"J Antimicrob Chemother"},{"key":"479_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.blo.0000137551.45447.89","volume":"430","author":"O Kandemir","year":"2005","unstructured":"Kandemir O, Oztuna V, Milcan A, Bayramo\u011flu A, Celik HH, Bayarslan C et al (2005) Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. Clin Orthop Relat Res 430:171\u2013175","journal-title":"Clin Orthop Relat Res"},{"key":"479_CR9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/AAC.37.9.1749","volume":"37","author":"H Yasuda","year":"1993","unstructured":"Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T (1993) Interaction between biofilms formed by Pseudomonas-aeruginosa and clarithromycin. Antimicrob Agents Chemother 37:1749\u20131755","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR10","first-page":"10","volume":"25","author":"J Parra-Ruiz","year":"2012","unstructured":"Parra-Ruiz J, Vidaillac C, Rybak MJ (2012) Macrolides and staphylococcal biofilms. Rev Esp Quimioter 25:10\u201316","journal-title":"Rev Esp Quimioter"},{"key":"479_CR11","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.00455-10","volume":"54","author":"J Parra-Ruiz","year":"2010","unstructured":"Parra-Ruiz J, Vidaillac C, Rose WE, Rybak MJ (2010) Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm. Antimicrob Agents Chemother 54:4329\u20134334","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40121-014-0055-5","volume":"4","author":"AD Hall Snyder","year":"2014","unstructured":"Hall Snyder AD, Vidaillac C, Rose W, McRoberts JP, Rybak MJ (2014) Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis in a novel in vitro PK\/PD model of bacterial biofilm. Infect Dis Ther 4:51\u201365","journal-title":"Infect Dis Ther"},{"key":"479_CR13","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1128\/AAC.00523-06","volume":"50","author":"O Murillo","year":"2006","unstructured":"Murillo O, Dom\u00e9nech A, Garcia A, Tubau F, Cabellos C, Gudiol F et al (2006) Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 50:4011\u20134017","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/infdis\/163.6.1369","volume":"163","author":"C Chuard","year":"1991","unstructured":"Chuard C, Lucet JC, Rohner P, Herrmann M, Auckenthaler R, Waldvogel FA et al (1991) Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 163:1369\u20131373","journal-title":"J Infect Dis"},{"key":"479_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/infdis\/146.4.487","volume":"146","author":"W Zimmerli","year":"1982","unstructured":"Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE (1982) Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 146:487\u2013497","journal-title":"J Infect Dis"},{"key":"479_CR16","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1128\/AAC.00226-10","volume":"54","author":"C Garrig\u00f3s","year":"2010","unstructured":"Garrig\u00f3s C, Murillo O, Euba G, Verdaguer R, Tubau F, Cabellos C et al (2010) Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 54:5251\u20135256","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijantimicag.2015.04.004","volume":"46","author":"C Haj El","year":"2015","unstructured":"El Haj C, Murillo O, Ribera A, Vivas M, Garcia-Somoza D, Tubau F et al (2015) Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus. Int J Antimicrob Agents 46:189\u2013195","journal-title":"Int J Antimicrob Agents"},{"key":"479_CR18","unstructured":"Cockerill FR, Wiker MA, Alder J, Dudley MN, Eliopoulos GM, Ferraro MJ et al. (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically\u202f; approved standard\u2014ninth edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standard Institute"},{"key":"479_CR19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jac\/33.5.959","volume":"33","author":"W Zimmerli","year":"1994","unstructured":"Zimmerli W, Frei R, Widmer AF, Rajacic Z (1994) Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 33:959\u2013967","journal-title":"J Antimicrob Chemother"},{"key":"479_CR20","unstructured":"Clinical and Laboratory Standards Institute (1999) Methods for determining bactericidal activity of antimicrobial agents; approved guideline M26-A. vol. 19"},{"key":"479_CR21","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/AAC.42.9.2385","volume":"42","author":"JD Alder","year":"1998","unstructured":"Alder JD, Ewing PJ, Nilius AM, Mitten M, Tovcimak A, Oleksijew A et al (1998) Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. Antimicrob Agents Chemother 42:2385\u20132390","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR22","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00181-13","volume":"57","author":"J Bauer","year":"2013","unstructured":"Bauer J, Siala W, Tulkens PM, Van Bambeke F (2013) A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms. Antimicrob Agents Chemother 57:2726\u20132737","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR23","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1128\/AAC.02681-14","volume":"58","author":"C Haj El","year":"2014","unstructured":"El Haj C, Murillo O, Ribera A, Vivas M, Garcia-Somoza D, Tubau F et al (2014) Comparative efficacies of cloxacillin-daptomycin and the standard cloxacillin-rifampin therapies against an experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 58:5576\u20135580","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/BF02013308","volume":"5","author":"B Berger-B\u00e4chi","year":"1986","unstructured":"Berger-B\u00e4chi B, Str\u00e4ssle A, Kayser FH (1986) Characterization of an isogenic set of methicillin-resistant and susceptible mutants of Staphylococcus aureus. Eur J Clin Microbiol 5:697\u2013701","journal-title":"Eur J Clin Microbiol"},{"key":"479_CR25","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00502-12","volume":"56","author":"AD Berti","year":"2012","unstructured":"Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE (2012) Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. Antimicrob Agents Chemother 56:5046\u20135053","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA (1998) Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1\u201310 (quiz 11\u20132)","journal-title":"Clin Infect Dis"},{"key":"479_CR27","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.00047-09","volume":"53","author":"AK John","year":"2009","unstructured":"John AK, Baldoni D, Haschke M, Rentsch K, Schaerli P, Zimmerli W et al (2009) Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 53:2719\u20132724","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.diagmicrobio.2014.05.022","volume":"80","author":"J Lora-Tamayo","year":"2014","unstructured":"Lora-Tamayo J, Parra-Ruiz J, Rodr\u00edguez-Pardo D, Barber\u00e1n J, Ribera A, Tornero E et al (2014) High doses of daptomycin (10\u00a0mg\/kg\/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study. Diagn Microbiol Infect Dis 80:66\u201371","journal-title":"Diagn Microbiol Infect Dis"},{"key":"479_CR29","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00264-013-1856-y","volume":"37","author":"K Jugun","year":"2013","unstructured":"Jugun K, Vaudaux P, Garbino J, Pagani L, Hoffmeyer P, Lew D et al (2013) The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections. Int Orthop 37:1375\u20131380","journal-title":"Int Orthop"},{"key":"479_CR30","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ et al (2011) Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18\u2013e55","journal-title":"Clin Infect Dis"},{"key":"479_CR31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","volume":"44","author":"DJ Skiest","year":"2006","unstructured":"Skiest DJ (2006) Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 44:655\u2013656","journal-title":"J Clin Microbiol"},{"key":"479_CR32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkt396","volume":"69","author":"O Gasch","year":"2014","unstructured":"Gasch O, Camoez M, Dom\u00ednguez MA, Padilla B, Pintado V, Almirante B et al (2014) Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin. J Antimicrob Chemother 69:568\u2013571","journal-title":"J Antimicrob Chemother"},{"key":"479_CR33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s101560050002","volume":"5","author":"M Sano","year":"1999","unstructured":"Sano M, Hirose T, Nishimura M, Takahashi S, Matsukawa M, Tsukamoto T (1999) Inhibitory action of clarithromycin on glycocalyx produced by MRSA. J Infect Chemother 5:10\u201315","journal-title":"J Infect Chemother"},{"key":"479_CR34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/AAC.38.1.138","volume":"38","author":"H Yasuda","year":"1994","unstructured":"Yasuda H, Ajiki Y, Koga T, Yokota T (1994) Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother 38:138\u2013141","journal-title":"Antimicrob Agents Chemother"},{"key":"479_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijantimicag.2008.06.030","volume":"32","author":"S Fujimura","year":"2008","unstructured":"Fujimura S, Sato T, Mikami T, Kikuchi T, Gomi K, Watanabe A (2008) Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices. Int J Antimicrob Agents 32:481\u2013484","journal-title":"Int J Antimicrob Agents"},{"key":"479_CR36","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jiac.2015.06.001","volume":"21","author":"S Fujimura","year":"2015","unstructured":"Fujimura S, Sato T, Hayakawa S, Kawamura M, Furukawa E, Watanabe A (2015) Antimicrobial efficacy of combined clarithromycin plus daptomycin against biofilms-formed methicillin-resistant Staphylococcus aureus on titanium medical devices. J Infect Chemother 21:756\u2013759","journal-title":"J Infect Chemother"},{"key":"479_CR37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00776-009-1366-3","volume":"14","author":"S Fujimura","year":"2009","unstructured":"Fujimura S, Sato T, Kikuchi T, Zaini J, Gomi K, Watanabe A (2009) Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilm-forming Staphylococcus aureus. J Orthop Sci 14:658\u2013661","journal-title":"J Orthop Sci"},{"key":"479_CR38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1348-0421.1994.tb01829.x","volume":"38","author":"S Mizobuchi","year":"1994","unstructured":"Mizobuchi S, Minami J, Jin F, Matsushita O, Okabe A (1994) Comparison of the virulence of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Microbiol Immunol 38:599\u2013605","journal-title":"Microbiol Immunol"},{"key":"479_CR39","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.04990-14","volume":"59","author":"AD Berti","year":"2015","unstructured":"Berti AD, Baines SL, Howden BP, Sakoulas G, Nizet V, Proctor RA et al (2015) Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics. Antimicrob Agents Chemother 59:2799\u20132806","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-016-0479-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T17:37:12Z","timestamp":1568396232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-016-0479-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s00430-016-0479-5","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,17]]}}}